KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to -$12.5 million.

  • Edwards Lifesciences' Gains from Investment Securities changed N/A to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 109565.22%. This contributed to the annual value of $72.9 million for FY2024, which is 37824.43% up from last year.
  • Edwards Lifesciences' Gains from Investment Securities amounted to -$12.5 million in Q3 2025.
  • In the past 5 years, Edwards Lifesciences' Gains from Investment Securities ranged from a high of $48.3 million in Q4 2024 and a low of -$102.6 million during Q2 2021
  • Over the past 5 years, Edwards Lifesciences' median Gains from Investment Securities value was -$4.7 million (recorded in 2025), while the average stood at -$11.5 million.
  • In the last 5 years, Edwards Lifesciences' Gains from Investment Securities soared by 11222.22% in 2021 and then crashed by 123636.36% in 2022.
  • Edwards Lifesciences' Gains from Investment Securities (Quarter) stood at -$18.1 million in 2021, then skyrocketed by 102.76% to $500000.0 in 2022, then crashed by 5480.0% to -$26.9 million in 2023, then skyrocketed by 279.55% to $48.3 million in 2024, then crashed by 125.88% to -$12.5 million in 2025.
  • Its last three reported values are -$12.5 million in Q3 2025, -$4.7 million for Q2 2025, and -$3.6 million during Q1 2025.